Cargando…

Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer

BACKGROUND: The time between the diagnosis of cancer and a planned definitive surgical procedure offers a strong and direct approach for assessing the impact of interventions (including lifestyle interventions) on the biology of the target tissue and the tumor. Despite the many strengths of presurgi...

Descripción completa

Detalles Bibliográficos
Autores principales: Demark-Wahnefried, Wendy, George, Stephen L, Switzer, Boyd R, Snyder, Denise C, Madden, John F, Polascik, Thomas J, Ruffin, Mack T, Vollmer, Robin T
Formato: Texto
Lenguaje:English
Publicado: Sage 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602610/
https://www.ncbi.nlm.nih.gov/pubmed/18559416
http://dx.doi.org/10.1177/1740774508091676
_version_ 1782162518821568512
author Demark-Wahnefried, Wendy
George, Stephen L
Switzer, Boyd R
Snyder, Denise C
Madden, John F
Polascik, Thomas J
Ruffin, Mack T
Vollmer, Robin T
author_facet Demark-Wahnefried, Wendy
George, Stephen L
Switzer, Boyd R
Snyder, Denise C
Madden, John F
Polascik, Thomas J
Ruffin, Mack T
Vollmer, Robin T
author_sort Demark-Wahnefried, Wendy
collection PubMed
description BACKGROUND: The time between the diagnosis of cancer and a planned definitive surgical procedure offers a strong and direct approach for assessing the impact of interventions (including lifestyle interventions) on the biology of the target tissue and the tumor. Despite the many strengths of presurgical models, there are practical issues and challenges that arise when using this approach. PURPOSE/METHODS: We recently completed an NIH-funded phase II trial that utilized a presurgical model in testing the comparative effects of flaxseed supplementation and/or dietary fat restriction on the biology and biomarkers associated with prostatic carcinoma. Herein, we report the rationale for our original design, discuss modifications in strategy, and relay experiences in implementing this trial related to the following topics: (1) subject accrual; (2) subject retention; (3) intervention delivery; and (4) retrieval and completion rates regarding the collection of paraffin-embedded and fresh frozen prostate tissue, blood, urine, ejaculate, anthropometric measures and survey data. RESULTS: This trial achieved its accrual target, i.e., a racially-representative (70% white, 30% minority) sample of 161 participants, low rates of attrition (7%); and collection rates that exceeded 90% for almost all biospecimens and survey data. While the experience gained from pilot studies was invaluable in designing this trial, the complexity introduced by the collection of several biospecimens, inclusion of a team of pathologists (to provide validated readings), and shifts in practice patterns related to prostatectomy, made it necessary to revise our protocol; lessons from our experiences are offered within this article. CONCLUSIONS: While our experience specifically relates to the implementation of a presurgical model-based trial in prostate cancer aimed at testing flaxseed-supplemented and fat-restricted diets, many of the lessons learned have broad application to trials that utilize a presurgical model or dietary modification within various cancer populations.
format Text
id pubmed-2602610
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Sage
record_format MEDLINE/PubMed
spelling pubmed-26026102009-01-26 Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer Demark-Wahnefried, Wendy George, Stephen L Switzer, Boyd R Snyder, Denise C Madden, John F Polascik, Thomas J Ruffin, Mack T Vollmer, Robin T Clin Trials Design BACKGROUND: The time between the diagnosis of cancer and a planned definitive surgical procedure offers a strong and direct approach for assessing the impact of interventions (including lifestyle interventions) on the biology of the target tissue and the tumor. Despite the many strengths of presurgical models, there are practical issues and challenges that arise when using this approach. PURPOSE/METHODS: We recently completed an NIH-funded phase II trial that utilized a presurgical model in testing the comparative effects of flaxseed supplementation and/or dietary fat restriction on the biology and biomarkers associated with prostatic carcinoma. Herein, we report the rationale for our original design, discuss modifications in strategy, and relay experiences in implementing this trial related to the following topics: (1) subject accrual; (2) subject retention; (3) intervention delivery; and (4) retrieval and completion rates regarding the collection of paraffin-embedded and fresh frozen prostate tissue, blood, urine, ejaculate, anthropometric measures and survey data. RESULTS: This trial achieved its accrual target, i.e., a racially-representative (70% white, 30% minority) sample of 161 participants, low rates of attrition (7%); and collection rates that exceeded 90% for almost all biospecimens and survey data. While the experience gained from pilot studies was invaluable in designing this trial, the complexity introduced by the collection of several biospecimens, inclusion of a team of pathologists (to provide validated readings), and shifts in practice patterns related to prostatectomy, made it necessary to revise our protocol; lessons from our experiences are offered within this article. CONCLUSIONS: While our experience specifically relates to the implementation of a presurgical model-based trial in prostate cancer aimed at testing flaxseed-supplemented and fat-restricted diets, many of the lessons learned have broad application to trials that utilize a presurgical model or dietary modification within various cancer populations. Sage 2008 /pmc/articles/PMC2602610/ /pubmed/18559416 http://dx.doi.org/10.1177/1740774508091676 Text en © Society for Clinical Trials 2008 http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Design
Demark-Wahnefried, Wendy
George, Stephen L
Switzer, Boyd R
Snyder, Denise C
Madden, John F
Polascik, Thomas J
Ruffin, Mack T
Vollmer, Robin T
Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer
title Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer
title_full Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer
title_fullStr Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer
title_full_unstemmed Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer
title_short Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer
title_sort overcoming challenges in designing and implementing a phase ii randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer
topic Design
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602610/
https://www.ncbi.nlm.nih.gov/pubmed/18559416
http://dx.doi.org/10.1177/1740774508091676
work_keys_str_mv AT demarkwahnefriedwendy overcomingchallengesindesigningandimplementingaphaseiirandomizedcontrolledtrialusingapresurgicalmodeltotestadietaryinterventioninprostatecancer
AT georgestephenl overcomingchallengesindesigningandimplementingaphaseiirandomizedcontrolledtrialusingapresurgicalmodeltotestadietaryinterventioninprostatecancer
AT switzerboydr overcomingchallengesindesigningandimplementingaphaseiirandomizedcontrolledtrialusingapresurgicalmodeltotestadietaryinterventioninprostatecancer
AT snyderdenisec overcomingchallengesindesigningandimplementingaphaseiirandomizedcontrolledtrialusingapresurgicalmodeltotestadietaryinterventioninprostatecancer
AT maddenjohnf overcomingchallengesindesigningandimplementingaphaseiirandomizedcontrolledtrialusingapresurgicalmodeltotestadietaryinterventioninprostatecancer
AT polascikthomasj overcomingchallengesindesigningandimplementingaphaseiirandomizedcontrolledtrialusingapresurgicalmodeltotestadietaryinterventioninprostatecancer
AT ruffinmackt overcomingchallengesindesigningandimplementingaphaseiirandomizedcontrolledtrialusingapresurgicalmodeltotestadietaryinterventioninprostatecancer
AT vollmerrobint overcomingchallengesindesigningandimplementingaphaseiirandomizedcontrolledtrialusingapresurgicalmodeltotestadietaryinterventioninprostatecancer